Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
An important feature of the development of many human and animal tumours is the appearance of pre-malignant benign lesions, some of which undergo further changes during progression to malignancy. Many of the currently accepted concepts of multi-stage carcinogenesis have been developed using an experimental model based on the chemical induction of tumours in mouse skin. In this system, many of the premalignant papillomas which arise are promoter-dependent, and appear to regress if promoter treatment is interrupted, whereas others progress to form autonomous benign lesions and, in some cases, malignant carcinomas. Although the number and nature of the events leading to malignancy are not known, DNA transfection experiments have led to the identification of several genes which may be qualitatively altered in tumour cells (see ref. 6 for review). We have previously shown that DNA from transplantable mouse skin carcinomas induced by chemical carcinogens has the ability to transform NIH/3T3 cells, and that the gene responsible for the transformation is an activated form of the mouse cellular Harvey-ras gene (c-rasH). We have now investigated the stage of carcinogenesis at which the proto-oncogene acquires transforming activity. We demonstrate that primary papillomas induced by chemical carcinogens in two different mouse strains have an activated c-rasH gene. This constitutes the first report of a benign tumour which contains DNA with detectable transforming activity. In addition, steady-state levels of c-rasH gene transcripts are elevated in the papillomas as compared with normal epidermis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, these G4 TERCÀ/À APC min mice exhibited a profound suppression of more advanced adenomatous lesions in association with significant intratumoral growth arrest and apoptosis (89).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“Quantitative analysis of mice with multiple intestinal neoplasia (min) provided further evidence that telomere shortening can dramatically impair tumor development in epithelial cells at specific stages in the malignant transformation process.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“In this APC min model, the addition of telomere dysfunction resulted in an increase in early neoplastic lesions probably due to chromosome instability resulting in increased loss of the remaining wild-type APC allele.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“The antitumor effects of telomere dysfunction resulted in dramatically increased survival in G4 TERCÀ/À APC min mice by preventing blood loss caused by gastrointestinal tract adenomas.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
In the citing paper
“Anaphase bridges, a hallmark of dysfunctional telomeres, are low in adenomas but increase substantially at the adenoma-carcinoma transition.Anaphase bridges become significantly more abundant at the pre-invasive and invasive colon cancer stages (89).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [89]
Citations
Cites
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Reddy, E. P., Reynolds, R. K., Santos, E., & Barbacid, M. (1982) · Nature · doi:10.1038/300149a0 · Cited by 1,391
Mutation and Cancer: A Model for Human Carcinogenesis2
Moolgavkar, S. H., & Knudson, A. G. (1981) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/66.6.1037 · Cited by 1,086
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
The Function and Mechanism of Promoters of Carcinogenesis
Boutwell, R. K., & Sivak, A. (1973) · CRC Critical Reviews in Toxicology · doi:10.3109/10408447309025704 · Cited by 746
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 623
Cooper, G. M. (1982) · Science · doi:10.1126/science.6285471 · Cited by 606
A Two-stage Theory of Carcinogenesis in Relation to the Age Distribution of Human Cancer
Armitage, P., & Doll, R. (1957) · British Journal of Cancer · doi:10.1038/bjc.1957.22 · Cited by 555
Oncogenes in solid human tumours
Pulciani, S., Santos, E., Lauver, A. V., Long, L. K., Aaronson, S. A., & Barbacid, M. (1982) · Nature · doi:10.1038/300539a0 · Cited by 478
Research works printed but not linked: 4
- Pierce, G. B. & Fennell, R. H. in Cancer Medicine (eds Holland, J. F. & Frei, E.) 149–167 (Lea & Febiger, Philadelphia, 1982).
- Hecker, E., Fusenig, N. E., Kunz, W., Marks, F. & Thielmann, H. W. (eds) Carcinogenesis Vol. 7 (Raven, New York, 1982).
- Burns, F. J., Vanderlaan, M., Snyder, E. & Albert, R. E. Carcinogenesis Vol. 2 (eds Slaga, T. J., Sivak, A. & Boutwell, R. K.) 91–96 (Raven, New York, 1978).
- Hennings, H. et al. Cancer Res. 41, 773–779 (1981).
Cited by
Items 301–400 of 516
Morrison, V. M., Burnett, A. K., & Craft, J. A. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90568-p · Cited by 19
Gap-junction disassembly and connexin 43 dephosphorylation induced by 18β-glycyrrhetinic acid
Guan, X., Wilson, S., Schlender, K. K., & Ruch, R. J. (1996) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199607)16:3<157::aid-mc6>3.0.co;2-e · Cited by 167
Transforming growth factor β1 enhances tumor promotion in mouse skin carcinogenesis
Pérez‐Lorenzo, R., Markell, L. M., Hogan, K. A., Yuspa, S. H., & Glick, A. B. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq041 · Cited by 18
Abel, E. L., & DiGiovanni, J. (2010) · Humana Press eBooks · doi:10.1007/978-1-61737-995-6_2 · Cited by 23
A transforming Kirsten ras oncogene in an oral squamous carcinoma
Howell, R. E., Wong, F., & Fenwick, R. G. (1990) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1990.tb00849.x · Cited by 18
Lambard, S. E., Burnett, A. K., Wolf, C. R., & Craft, J. A. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90421-z · Cited by 18
Cancer Risk Associated With Therapeutic Irradiation of Skin
Burns, F. J. (1989) · Archives of Dermatology · doi:10.1001/archderm.1989.01670190113016 · Cited by 18
Activation of Protooncogenes in Mouse Lung Tumors
You, M., Wang, Y., Lineen, A., Stoner, G. D., You, L., Maronpot, R. R., & Anderson, M. W. (1991) · Experimental Lung Research · doi:10.3109/01902149109064426 · Cited by 18
Biological and Molecular Aspects of Radiation Carcinogenesis in Mouse Skin
Bowden, G. T., Jaffe, D. R., & Andrews, K. L. (1990) · Radiation Research · doi:10.2307/3577771 · Cited by 18
Self-citationMalignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
Storer, R. D., Stein, R. B., Sina, J. F., DeLuca, J. G., Allen, H. L., & Bradley, M. O. (1986) · PubMed · Cited by 18
Crosstalk between Desmoglein 2 and Patched 1 accelerates chemical-induced skin tumorigenesis
Brennan-Crispi, D. M., Hossain, C., Sahu, J., Brady, M., Galdo, N. A. R., & Mahoney, M. G. (2015) · Oncotarget · doi:10.18632/oncotarget.3309 · Cited by 17
Sutter, C., Strickland, J. E., Welty, D. J., Yuspa, S. H., Winter, H., & Schweizer, J. (1991) · Molecular Carcinogenesis · doi:10.1002/mc.2940040610 · Cited by 17
Differences between preneoplastic cells, neoplastic cells and their normal counterparts
Boyd, N. M., & Reade, P. C. (1988) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.1988.tb01534.x · Cited by 17
Cytogenetic analysis of malignant skin tumors induced in chemically treated TG.AC transgenic mice
French, J. E., Libbus, B. L., Hansen, L. A., Spalding, J. W., Tice, R. R., Mahler, J. F., & Tennant, R. W. (1994) · Molecular Carcinogenesis · doi:10.1002/mc.2940110407 · Cited by 17
Ghanayem, B. I., Matthews, H. B., & Maronpot, R. R. (1991) · Toxicologic Pathology · doi:10.1177/019262339101900310 · Cited by 16
Differential Gene Expression during Multistage Carcinogenesis
Bowden, G. T., & Krieg, P. (1991) · Environmental Health Perspectives · doi:10.1289/ehp.919351 · Cited by 16
Self-citationHuber, B. E., Heilman, C. A., & Thorgeirsson, S. S. (1989) · Hepatology · doi:10.1002/hep.1840090517 · Cited by 16
Radinsky, R., & Culp, L. A. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480126 · Cited by 17
Activation of Oncogenes by Chemical Carcinogens
Anderson, M. W., & Reynolds, S. H. (1989) · Springer eBooks · doi:10.1007/978-1-4684-5523-6_15 · Cited by 16
Saito, S. (1992) · The Keio Journal of Medicine · doi:10.2302/kjm.41.80 · Cited by 16
Uhmann, A., Heß, I., Frommhold, A., König, S., Zabel, S., Nitzki, F., Dittmann, K., Lühder, F., Christiansen, H., REIFENBERGER, J., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.157 · Cited by 15
Modes of Retrotransposition of Long Interspersed Element-1 by Environmental Factors
Ishizaka, Y., Okudaira, N., Tamura, M., Iijima, K., Shimura, M., Goto, M., & Okamura, T. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00191 · Cited by 16
Búa, S., Sotiropoulou, P., Sgarlata, C., Borlado, L. R., Eguren, M., Domínguez, O., Ortega, S., Malumbres, M., Blanpain, C., & Méndez, J. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1120919 · Cited by 15
Albert, R. E. (1989) · Environmental Health Perspectives · doi:10.1289/ehp.8981103 · Cited by 15
Sato, H., Suzuki, K. T., Sone, H., Yamano, Y., Kagawa, J., & Aoki, Y. (2003) · Environmental Research · doi:10.1016/s0013-9351(03)00063-x · Cited by 15
Hathway, D. E. (2000) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.1999.tb00042.x · Cited by 15
Protein Kinase C in Neoplastic Cells
Rotenberg, S. A., & Weinstein, I. B. (1991) · Elsevier eBooks · doi:10.1016/b978-0-12-564498-3.50005-4 · Cited by 15
Ha‐Ras stimulates uptake and phosphorylation of ethanolamine: inhibition by wortmannin
Kiss, Z., & Crilly, K. S. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01371-7 · Cited by 15
Schneider, B. L., Bowden, G. T., Sutter, C., Schweizer, J., Han, K.-A., & Kulesz-Martin, M. F. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12366051 · Cited by 15
Self-citationSistare, F. D., Thompson, K. L., Honchel, R., & DeGeorge, J. J. (2002) · International Journal of Toxicology · doi:10.1080/10915810252826028 · Cited by 17
Neoplastic transformation of a human kidney epithelial cell line transfected with V‐HA‐ras oncogene
Haugen, A., Ryberg, D., Hansteen, I., & Amstad, P. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910450333 · Cited by 15
Cichutek, K., & DUESBERG, P. H. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1377-1383.1989 · Cited by 15
Guerrero, I., Villasanté, A., Diamond, L. E., Berman, J. W., Newcomb, E. W., Steinberg, J. J., Lake, R., & Pellicer, À. (1986) · Leukemia Research · doi:10.1016/0145-2126(86)90306-1 · Cited by 15
Loss of endogenous Nfatc1 reduces the rate of DMBA/TPA-induced skin tumorigenesis
Goldstein, J., Roth, E. M., Roberts, N. A., Zwick, R. K., Lin, S. Y., Fletcher, S. A., Tadeu, A. M. B., Wu, C. J., Beck, A. P., Zeiss, C. J., et al. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-05-0282 · Cited by 17
Kedinger, V., Muller, S., & Gronemeyer, H. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-34 · Cited by 14
Chen, H., Liu, J., Merrick, B. A., & Waalkes, M. P. (2001) · Molecular Carcinogenesis · doi:10.1002/1098-2744(200102)30:2<111::aid-mc1019>3.0.co;2-l · Cited by 110
Cancer Genes by Illegitimate Recombinationa
DUESBERG, P. H., Zhou, R., & Goodrich, D. W. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb16477.x · Cited by 14
Expression of the c‐ fos oncogene in chemically‐induced mouse tumours and in human skin tumours
Urabe, A., NAKAYAMA, J., Taniguchi, S., Terao, H., & Hori, Y. (1992) · The Journal of Pathology · doi:10.1002/path.1711680307 · Cited by 14
Brissette, J. L., Missero, C., Yuspa, S. H., & Dotto, G. P. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940070105 · Cited by 14
Altered telomere homeostasis and resistance to skin carcinogenesis in Suv39h1 transgenic mice
Petti, E., Jordi, F., Buemi, V., Dinami, R., Benetti, R., Blasco, M. A., & Schoeftner, S. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1021517 · Cited by 13
Volume, trend and citation analyses of skin related publications from 1966 to 2003
WILGUS, M., ADCOCK, P., & TAKASHIMA, A. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2004.10.010 · Cited by 13
Consequences of altered oncogene expression in rodent cells
Pragnell, I. B., Spandidos, D. A., & Wilkie, N. M. (1985) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1985.0085 · Cited by 13
Frayssinet, C., & Frayssinet, C. (1989) · Cancer Letters · doi:10.1016/0304-3835(89)90060-8 · Cited by 12
Gergely, P. A., Murnyák, B., Bencze, J., Kurucz, A., Varjas, T., Gombos, K., & Hortobágyi, T. (2019) · BioMed Research International · doi:10.1155/2019/8670398 · Cited by 12
Pitot, H. C. (1986) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30832-1 · Cited by 12
Biologic and molecular characterization of two newly isolated ras-containing murine leukemia viruses
Fredrickson, T. N., O'Neill, R. R., Rutledge, R., Theodore, T. S., Martin, M. A., Ruscetti, S. K., Austin, J. B., & Hartley, J. W. (1987) · Journal of Virology · doi:10.1128/jvi.61.7.2109-2119.1987 · Cited by 12
Analysis of Proto-oncogene Expression During Liver Regeneration and Hepatocarcinogenesis
Fausto, N., & Shank, P. R. (1987) · Springer eBooks · doi:10.1007/978-4-431-68349-0_5 · Cited by 12
Oncogenes in the myelodysplastic syndrome
Jacobs, A. (1989) · Blood Reviews · doi:10.1016/0268-960x(89)90005-2 · Cited by 12
Wyde, M. E. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh233 · Cited by 11
Characteristics of Disease and Some Exposure Considerations
Axelson, O., & Söderkvist, P. (1991) · Applied Occupational and Environmental Hygiene · doi:10.1080/1047322x.1991.10387909 · Cited by 12
Smith, G. J., & Grisham, J. W. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(87)80196-1 · Cited by 11
Sipes, N. J., Lyons, R. M., & Moses, H. L. (1990) · Molecular Carcinogenesis · doi:10.1002/mc.2940030106 · Cited by 11
Polyoma Virus Middle T Gene Can Trigger Malignant Transformation of Early Passage Rodent Cells
Spandidos, D. A., & Riggio, M. P. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-4-793 · Cited by 11
Effect of Sodium Arsenite on Mouse Skin Carcinogenesis
Palmieri, M. A., & Molinari, B. L. (2015) · Toxicologic Pathology · doi:10.1177/0192623314566240 · Cited by 10
Rapp, U. R., Storm, S. M., & Cleveland, J. L. (1987) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-72624-8_97 · Cited by 10
Skin Cancers and the Contribution of Rho GTPase Signaling Networks to Their Progression
Pecora, A., Laprise, J., Dahmene, M., & Laurin, M. (2021) · Cancers · doi:10.3390/cancers13174362 · Cited by 11
Carcinogenic Effects of MGP-7 and B[a]P on the Hamster Cheek Pouch
Brandon, J. L., Conti, C. J., Goldstein, L. S., DiGiovanni, J., & Gimenez-Conti, I. B. (2009) · Toxicologic Pathology · doi:10.1177/0192623309344203 · Cited by 10
GARTE, S. J., & Hochwalt, A. E. (1989) · Environmental Health Perspectives · doi:10.1289/ehp.898129 · Cited by 10
Coumarin modulates the cell-cycle progression of an MTV-EJras cell line
Kahn, J. S., Preis, P., Waldman, F. M., & Tseng, A. (1994) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01377118 · Cited by 10
Goyette, M., Dolan, M., Kaufmann, W. K., Kaufman, D. G., Shank, P. R., & Fausto, N. (1988) · Molecular Carcinogenesis · doi:10.1002/mc.2940010108 · Cited by 10
Activation of H-ras-1 Oncogenes by Chemical Carcinogens
Zarbl, H., Sukumar, S. V., Arthur, A. L., Martín-Zanca, D., & Barbacid, M. (1986) · Springer eBooks · doi:10.1007/978-1-4615-9462-8_42 · Cited by 11
Cellular aging is a critical determinant of primary cell resistance to v-src transformation
Tavoloni, N., & Inoue, H. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.237-247.1997 · Cited by 10
Oncogene expression and oral cancer
Pillai, R. M., Reddiar, K. S., & Balaram, P. (1991) · Journal of Surgical Oncology · doi:10.1002/jso.2930470209 · Cited by 10
Boiocchi, M., Dolcetti, R., Maestro, R., Feriotto, G., Rizzo, S., Re, V. D., & Sonego, F. (1990) · Leukemia Research · doi:10.1016/0145-2126(90)90007-v · Cited by 10
Cancer genes generated by rare chromosomal rearrangements rather than activation of oncogenes
DUESBERG, P. H. (1987) · Medical Oncology and Tumor Pharmacotherapy · doi:10.1007/bf02934512 · Cited by 9
Yusuf, N., Nasti, T. H., Ahmad, I., Chowdhury, S., Mohiuddin, H., Xu, H., Athar, M., Timares, L., & Elmets, C. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402804 · Cited by 9
Zhang, S., Bauer, B. A., Mitsunaga, S., Goodrow, T. L., & Klein–Szanto, A. J. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940120204 · Cited by 9
Ananthaswamy, H. N., Price, J. E., Tainsky, M. A., Goldberg, L. H., & Bales, E. S. (1989) · Clinical & Experimental Metastasis · doi:10.1007/bf01753682 · Cited by 9
Characterization of the Stage of Progression in Hepatocarcinogenesis in the Rat
Pitot, H. C. (1991) · Springer eBooks · doi:10.1007/978-1-4684-5994-4_2 · Cited by 9
Lee, G., Sakai, R., Nagao, M., & Kitagawa, T. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470112 · Cited by 9
Regulatory elements in the first intron of the mouse ha‐ras gene
Telliez, J., Plumb, M., Balmain, A., & Bailleul, B. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940120305 · Cited by 9
Self-citationGARTE, S. J. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)90961-1 · Cited by 9
Randerath, K., Agrawal, H. P., & Randerath, E. (1985) · Cancer Letters · doi:10.1016/0304-3835(85)90006-0 · Cited by 9
High Frequency of ras Oncogene Activation in Benign and Malignant Human Thyroid Tumours
Lemoine, N. R., Mayall, E. S., Wyllie, F. S., & Wynford‐Thomas, D. (1989) · Springer eBooks · doi:10.1007/978-1-4757-1235-3_6 · Cited by 9
The Malignant Conversion Step of Mouse Skin Carcinogenesis
Yuspa, S. H., Hennings, H., Roop, D. R., Strickland, J., & Greenhalgh, D. A. (1990) · Environmental Health Perspectives · doi:10.1289/ehp.9088193 · Cited by 8
Activated Akt-1 in specific cell populations during multi-stage skin carcinogenesis.
Affara, N. I., Schanbacher, B. L., Mihm, M. J., Cook, A. C., Pei, P., Mallery, S. R., Trempus, C. S., Bauer, J. A., & Robertson, F. M. (2004) · PubMed · Cited by 9
López, C. A., Hsiao, W. L. W., & Weinstein, I. B. (1989) · PubMed · Cited by 8
Tavoloni, N., Inoue, H., Sabe, H., & Hanafusa, H. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.2.475 · Cited by 8
Johnson, D. G., Coleman, A., Powell, K. L., & MacLeod, M. C. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199710)20:2<216::aid-mc8>3.0.co;2-k · Cited by 12
Carneiro, F., David, L., Sunkel, C. E., Lopes, C., & Sobrinho-Simões, M. A. (1992) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)81203-3 · Cited by 9
Miyaki, M., Akamatsu, N., Sato, C., & Utsunomiya, J. (1988) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(88)90217-5 · Cited by 8
Suppression of ras oncogene-mediated transformation
Schäfer, R. (2006) · Springer eBooks · doi:10.1007/bfb0031031 · Cited by 11
Genetic Predisposition to Cutaneous Squamous Cell Carcinoma
Ng, Y.-Z., Jasbani, H. S., & Andrew, P. (2011) · InTech eBooks · doi:10.5772/26714 · Cited by 7
Hiwasa, T., Sawada, T., & Sakiyama, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9181 · Cited by 7
Applications of Nanoparticles for Treating Cutaneous Infection
Westendorf, A. M. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.412 · Cited by 7
Kiss, A., Koppel, A. C., Anders, J., Cataisson, C., Yuspa, S. H., Blumenberg, M., & Efimova, T. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22303 · Cited by 8
Oncogene expression of fanft‐ or BBN‐induced rat urothelial cells
Dêbiec‐Rychter, M., Jones, R. F., Zukowski, K. L., & Wang, C. Y. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460527 · Cited by 7
Hirai, H., Nishida, J., & Takaku, F. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(87)80093-1 · Cited by 7
The Role of Oncogene Activation in Chemical Carcinogenesis
Cooper, C. S. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-74778-6_12 · Cited by 7
Alterations in Epidermal Differentiation in Skin Carcinogenesis
Yuspa, S. H. (1985) · Jerusalem Symposia on Quantum Chemistry and Biochemistry · doi:10.1007/978-94-009-5466-3_8 · Cited by 7
Regulation of Retrotransposition of Long Interspersed Element-1 by Mitogen-Activated Protein Kinases
Ishizaka, Y., Okudaira, N., & Okamur, T. (2012) · InTech eBooks · doi:10.5772/38402 · Cited by 6
The Role of Non-ras Transforming Genes in Chemical Carcinogenesis
Cooper, C. S. (1991) · Environmental Health Perspectives · doi:10.1289/ehp.919333 · Cited by 6
Mechanisms and Consequences of Mutation Induction in Mammalian Cells
Sarasin, A. R., Bourre, F., Daya–Grosjean, L., Gentil, A., Madzak, C., & Stary, A. (1990) · International Journal of Radiation Biology · doi:10.1080/09553009014550841 · Cited by 8
Pan, Y., Yan, C., Hu, Y., Fan, Y., Pan, Q., Wan, Q., Torcivia-Rodriguez, J., & Mazumder, R. (2017) · Scientific Reports · doi:10.1038/srep42169 · Cited by 6
Immunohistochemical expression of N-ras oncogene is a late event in head and neck carcinomas
McDonald, J. S., Wilson, K. M. O., Gartside, P. S., Sonkk, R. L., Pavelić, L., Okum, E. J., Neanen, J., Gluckman, J. L., & Pavelić, Z. P. (1996) · Pathology & Oncology Research · doi:10.1007/bf02893944 · Cited by 6
Structural analysis of the mouse c‐HA‐ras gene promoter
Plumb, M., Telliez, J., Fee, F., Daubersies, P., Bailleul, B., & Balmain, A. (1991) · Molecular Carcinogenesis · doi:10.1002/mc.2940040205 · Cited by 6
Self-citationAn approach to the molecular mechanisms of cancer induction
Balmain, A., Quintanilla, M., Brown, K., & Ramsden, M. (1986) · The Journal of Pathology · doi:10.1002/path.1711490103 · Cited by 6
Self-citationTHE MALIGNANT POTENTIAL OF PAPILLOMAVIRUS *
Dyall‐Smith, D. J., & Varigos, G. (1985) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.1985.tb01759.x · Cited by 6
Feo, F., Garcea, R., Daino, L., Pascale, R. M., Frassetto, S., Cozzolino, P., Vannini, M. G., Ruggiu, M. E., Simile, M. M., & Puddu, M. (1988) · Springer eBooks · doi:10.1007/978-1-4757-9640-7_46 · Cited by 6
Critical Events in Skin Tumor Promotion and Progression
Slaga, T. J. (1991) · Springer eBooks · doi:10.1007/978-1-4684-5994-4_3 · Cited by 6
Metadata
- Authors
- Balmain, A., Ramsden, M., Bowden, G. T., & Smith, J.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- ORCID
- Balmain, Allan
- Venue
- Nature
- Published
- 1984-02
- Volume
- 307
- Issue
- 5952
- Pages
- 658-660
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2015936619
- Cited by
- 529
- References
- 19
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 4 · 2016: 5 · 2015: 16 · 2014: 5 · 2013: 9 · 2012: 9
- FWCI
- 19.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- skin papilloma, chemical carcinogenesis, precancerous lesions, proto-oncogene activation, transforming activity, gene expression, epidermis
- MeSH terms
- Proto-Oncogene Mas, Animals, Cell Transformation, Neoplastic, Gene Expression Regulation, Oncogenes, Papilloma, Skin Neoplasms, Transcription, Genetic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.